Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
28 /100
MEDIUM RISK
Score updated Oct 27, 2026

NUVB — Nuvation Bio Inc. Dilution Risk Tracker

Track NUVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NUVB — Get alerts when the score changes →

As of October 27, 2026, Nuvation Bio Inc. (NUVB) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Nuvation Bio Inc. has a market capitalization of $1.61B, 351.12M shares outstanding, 234 institutional holders tracked. Stored dilution-related fields include 2.90M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 15% potential dilution
• Elevated convertible risk (60/100)
🔔 Track NUVB — Get forecast alerts →

Market Data

Market Cap$1.61B
Shares Outstanding351.12M
Float237.62M
Cash$660.96M
Debt$248.52M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore28/100DilutionWatch score record
Shares Outstanding351.12MVerified float table or market cache
Public Float237.62MVerified float table or market cache
Market Cap$1.61BMarket data cache
Cash Runway109.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.90MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

NUVB SEC Filing Activity — Last 12 Months

Shares outstanding reported by NUVB on the cover page of its latest 10-K/10-Q: 351.12M as of August 03, 2026.

DilutionWatch recorded 2 registration or prospectus documents for NUVB (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)2Jun 26, 2026
8-Kcurrent report (material event)4Aug 06, 2026
10-Qquarterly report1Aug 06, 2026
DEF 14Aproxy statement1Apr 10, 2026
3initial insider ownership18Aug 21, 2026

Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)
234 institutional holders · 249.35M shares
#1 FMR LLC 51.99M shares
#2 Decheng Capital LLC 25.95M shares
#3 BlackRock, Inc. 25.10M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest63.22M
Days to Cover9.7
% of Float26.6%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2026-08-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NUVB Dilution Snapshot

Nuvation Bio Inc. (NUVB) has a DilutionScore of 28/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NUVB's DilutionScore is currently 28/100 (Medium risk), with 5 score changes tracked over 89 days. The score improved from 24/100 (Low risk).

Period Score Risk Level Duration
Oct 25 – Oct 27, 202628/100MEDIUM3 days
Oct 21 – Oct 24, 202624/100LOW4 days
Oct 17 – Oct 20, 202628/100MEDIUM4 days
Aug 22 – Oct 16, 202624/100LOW56 days
Aug 14 – Aug 21, 202628/100MEDIUM7 days
Jul 30 – Aug 13, 202624/100LOW15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NUVB shares outstanding have increased 1.6% from 341.83M (Mar 2026) to 347.20M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 09, 2026347.20M237.62M▲ 0.07%
May 06, 2026347.20M237.45M▲ 0.17%
Apr 18, 2026346.69M237.04M▲ 0.66%
Apr 13, 2026346.60M235.48M▲ 0.29%
Mar 05, 2026341.83M234.81M▲ 0.95%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NUVB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NUVB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NUVB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NUVB
NUVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.